Description
USP797 PHARMACY SAMPLING AND REPORTING - EO 14398
Base award description: USP797 PHARMACY SAMPLING AND REPORTING
Modification chain · 10 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-02-08+$29,700= $29,700
- Mod P000012024-01-12+$30,742= $60,442
- Mod P000022024-01-24+$27,114= $87,556
- Mod P000032024-11-08-$1,708= $85,848
- Mod P000042025-01-10+$56,563= $142,412
- Mod P000052025-04-10+$0= $142,412
- Mod P000062026-01-16+$58,541= $200,952
- Mod P000072026-01-26-$15,593= $185,359
- Mod P000082026-03-24-$12,609= $172,750
- Mod P000092026-06-05+$0= $172,750
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-02-08 | +$29,700 | $29,700 | USP797 PHARMACY SAMPLING AND REPORTING |
| Mod P00001· EXERCISE AN OPTION | 2024-01-12 | +$30,742 | $60,442 | USP797 PHARMACY SAMPLING AND REPORTING - OPTION 1 |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-01-24 | +$27,114 | $87,556 | USP797 PHARMACY SAMPLING AND REPORTING - ADD SAMPLES PER USP STANDARDS CHANGE |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-11-08 | −$1,708 | $85,848 | USP797 PHARMACY SAMPLING AND REPORTING - ADJUST THE QUANTITY |
| Mod P00004· EXERCISE AN OPTION | 2025-01-10 | +$56,563 | $142,412 | USP797 PHARMACY SAMPLING AND REPORTING - OPTION 2 |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-10 | +$0 | $142,412 | USP797 PHARMACY SAMPLING AND REPORTING - EXECUTIVE ORDER 13899 |
| Mod P00006· EXERCISE AN OPTION | 2026-01-16 | +$58,541 | $200,952 | USP797 PHARMACY SAMPLING AND REPORTING - OPTION 3 |
| Mod P00007· FUNDING ONLY ACTION | 2026-01-26 | −$15,593 | $185,359 | USP797 PHARMACY SAMPLING AND REPORTING - DE-OBLIGATE UNUSED FY24 FUNDS |
| Mod P00008· FUNDING ONLY ACTION | 2026-03-24 | −$12,609 | $172,750 | USP797 PHARMACY SAMPLING AND REPORTING - DE-OBLIGATE UNUSED FY25 FUNDS |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-06-05 | +$0 | $172,750 | USP797 PHARMACY SAMPLING AND REPORTING - EO 14398 |
Related awards · 6
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI E3C2X74KTN38)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24625F0061 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · H173 · QUALITY CONTROL- FOOD PREPARATION AND SERVING EQUIPMENT | $93,120 | FY2025 |
Other recipients under Q301 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226N0689 | CENTRAL TOX LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $79,995 | FY2026 |
| 36C24226N0614 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $2,352,838 | FY2026 |
| 36C24226A0050 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $0 | FY2026 |
| 36C24226N0607 | QUEST DIAGNOSTICS INCORPORATED | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $675,002 | FY2026 |
| 36C24226N0524 | WYOMING COUNTY COMMUNITY HOSPITAL | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $19,400 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24223P0449_3600_-NONE-_-NONE- · retrieved 2026-09-27.